Cargando…
A call to action: Community pharmacists to address COVID-19–related behavioral health concerns
Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720695/ https://www.ncbi.nlm.nih.gov/pubmed/33303338 http://dx.doi.org/10.1016/j.japh.2020.11.010 |
_version_ | 1783619898680803328 |
---|---|
author | Robinson, Jennifer D. Johnson, Nancy Brand-Eubanks, Damianne C. Kim, Anne P. |
author_facet | Robinson, Jennifer D. Johnson, Nancy Brand-Eubanks, Damianne C. Kim, Anne P. |
author_sort | Robinson, Jennifer D. |
collection | PubMed |
description | Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way. |
format | Online Article Text |
id | pubmed-7720695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77206952020-12-10 A call to action: Community pharmacists to address COVID-19–related behavioral health concerns Robinson, Jennifer D. Johnson, Nancy Brand-Eubanks, Damianne C. Kim, Anne P. J Am Pharm Assoc (2003) Science and Practice Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way. Elsevier 2021 2020-12-07 /pmc/articles/PMC7720695/ /pubmed/33303338 http://dx.doi.org/10.1016/j.japh.2020.11.010 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Science and Practice Robinson, Jennifer D. Johnson, Nancy Brand-Eubanks, Damianne C. Kim, Anne P. A call to action: Community pharmacists to address COVID-19–related behavioral health concerns |
title | A call to action: Community pharmacists to address COVID-19–related behavioral health concerns |
title_full | A call to action: Community pharmacists to address COVID-19–related behavioral health concerns |
title_fullStr | A call to action: Community pharmacists to address COVID-19–related behavioral health concerns |
title_full_unstemmed | A call to action: Community pharmacists to address COVID-19–related behavioral health concerns |
title_short | A call to action: Community pharmacists to address COVID-19–related behavioral health concerns |
title_sort | call to action: community pharmacists to address covid-19–related behavioral health concerns |
topic | Science and Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720695/ https://www.ncbi.nlm.nih.gov/pubmed/33303338 http://dx.doi.org/10.1016/j.japh.2020.11.010 |
work_keys_str_mv | AT robinsonjenniferd acalltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT johnsonnancy acalltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT brandeubanksdamiannec acalltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT kimannep acalltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT robinsonjenniferd calltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT johnsonnancy calltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT brandeubanksdamiannec calltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns AT kimannep calltoactioncommunitypharmaciststoaddresscovid19relatedbehavioralhealthconcerns |